Literature DB >> 21730289

Regulation of androgen receptor-mediated transcription by RPB5 binding protein URI/RMP.

Paolo Mita1, Jeffrey N Savas, Nabil Djouder, John R Yates, Susan Ha, Rachel Ruoff, Eric D Schafler, Jerome C Nwachukwu, Naoko Tanese, Nicholas J Cowan, Jiri Zavadil, Michael J Garabedian, Susan K Logan.   

Abstract

Androgen receptor (AR)-mediated transcription is modulated by interaction with coregulatory proteins. We demonstrate that the unconventional prefoldin RPB5 interactor (URI) is a new regulator of AR transcription and is critical for antagonist (bicalutamide) action. URI is phosphorylated upon androgen treatment, suggesting communication between the URI and AR signaling pathways. Whereas depletion of URI enhances AR-mediated gene transcription, overexpression of URI suppresses AR transcriptional activation and anchorage-independent prostate cancer cell growth. Repression of AR-mediated transcription is achieved, in part, by URI binding and regulation of androgen receptor trapped clone 27 (Art-27), a previously characterized AR corepressor. Consistent with this idea, genome-wide expression profiling in prostate cancer cells upon depletion of URI or Art-27 reveals substantially overlapping patterns of gene expression. Further, depletion of URI increases the expression of the AR target gene NKX-3.1, decreases the recruitment of Art-27, and increases AR occupancy at the NKX-3.1 promoter. While Art-27 can bind AR directly, URI is bound to chromatin prior to hormone-dependent recruitment of AR, suggesting a role for URI in modulating AR recruitment to target genes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21730289      PMCID: PMC3165545          DOI: 10.1128/MCB.05429-11

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  33 in total

1.  Loss of HCF-1-chromatin association precedes temperature-induced growth arrest of tsBN67 cells.

Authors:  J Wysocka; P T Reilly; W Herr
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

2.  Interaction with general transcription factor IIF (TFIIF) is required for the suppression of activated transcription by RPB5-mediating protein (RMP).

Authors:  Wenxiang Wei; Jun Xia Gu; Cui Qing Zhu; Feng Yan Sun; Dorjbal Dorjsuren; Yong Lin; Seishi Murakami
Journal:  Cell Res       Date:  2003-04       Impact factor: 25.617

3.  Control of nutrient-sensitive transcription programs by the unconventional prefoldin URI.

Authors:  Matthias Gstaiger; Brian Luke; Daniel Hess; Edward J Oakeley; Christiane Wirbelauer; Marc Blondel; Marc Vigneron; Matthias Peter; Wilhelm Krek
Journal:  Science       Date:  2003-11-14       Impact factor: 47.728

4.  Integrative genomic profiling of human prostate cancer.

Authors:  Barry S Taylor; Nikolaus Schultz; Haley Hieronymus; Anuradha Gopalan; Yonghong Xiao; Brett S Carver; Vivek K Arora; Poorvi Kaushik; Ethan Cerami; Boris Reva; Yevgeniy Antipin; Nicholas Mitsiades; Thomas Landers; Igor Dolgalev; John E Major; Manda Wilson; Nicholas D Socci; Alex E Lash; Adriana Heguy; James A Eastham; Howard I Scher; Victor E Reuter; Peter T Scardino; Chris Sander; Charles L Sawyers; William L Gerald
Journal:  Cancer Cell       Date:  2010-06-24       Impact factor: 31.743

5.  HSP90 and its R2TP/Prefoldin-like cochaperone are involved in the cytoplasmic assembly of RNA polymerase II.

Authors:  Séverine Boulon; Bérengère Pradet-Balade; Céline Verheggen; Dorothée Molle; Stéphanie Boireau; Marya Georgieva; Karim Azzag; Marie-Cécile Robert; Yasmeen Ahmad; Henry Neel; Angus I Lamond; Edouard Bertrand
Journal:  Mol Cell       Date:  2010-09-24       Impact factor: 17.970

Review 6.  The development of androgen-independent prostate cancer.

Authors:  B J Feldman; D Feldman
Journal:  Nat Rev Cancer       Date:  2001-10       Impact factor: 60.716

7.  Identification and characterization of ART-27, a novel coactivator for the androgen receptor N terminus.

Authors:  Steven M Markus; Samir S Taneja; Susan K Logan; Wenhui Li; Susan Ha; Adam B Hittelman; Inez Rogatsky; Michael J Garabedian
Journal:  Mol Biol Cell       Date:  2002-02       Impact factor: 4.138

8.  Formation of the androgen receptor transcription complex.

Authors:  Yongfeng Shang; Molly Myers; Myles Brown
Journal:  Mol Cell       Date:  2002-03       Impact factor: 17.970

9.  ART-27, an androgen receptor coactivator regulated in prostate development and cancer.

Authors:  Samir S Taneja; Susan Ha; Nicole K Swenson; Inés Pineda Torra; Serge Rome; Paul D Walden; Hong Ying Huang; Ellen Shapiro; Michael J Garabedian; Susan K Logan
Journal:  J Biol Chem       Date:  2004-01-07       Impact factor: 5.157

10.  Molecular determinants of resistance to antiandrogen therapy.

Authors:  Charlie D Chen; Derek S Welsbie; Chris Tran; Sung Hee Baek; Randy Chen; Robert Vessella; Michael G Rosenfeld; Charles L Sawyers
Journal:  Nat Med       Date:  2003-12-21       Impact factor: 53.440

View more
  21 in total

1.  URI expression in cervical cancer cells is associated with higher invasion capacity and resistance to cisplatin.

Authors:  Junxia Gu; Yuting Liang; Longwei Qiao; Yaojuan Lu; Xiaoxia Hu; Dongwei Luo; Na Li; Leilei Zhang; Yiyang Chen; Jialu Du; Qiping Zheng
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

2.  Anti-androgen resistance in prostate cancer cells chronically induced by interleukin-1β.

Authors:  Julia A Staverosky; Xin-Hua Zhu; Susan Ha; Susan K Logan
Journal:  Am J Clin Exp Urol       Date:  2013-12-25

3.  URI Regulates KAP1 Phosphorylation and Transcriptional Repression via PP2A Phosphatase in Prostate Cancer Cells.

Authors:  Paolo Mita; Jeffrey N Savas; Erica M Briggs; Susan Ha; Veena Gnanakkan; John R Yates; Diane M Robins; Gregory David; Jef D Boeke; Michael J Garabedian; Susan K Logan
Journal:  J Biol Chem       Date:  2016-10-25       Impact factor: 5.157

4.  Meeting Report: The Role of the Mobilome in Cancer.

Authors:  Daniel Ardeljan; Martin S Taylor; Kathleen H Burns; Jef D Boeke; Michael Graham Espey; Elisa C Woodhouse; Thomas Kevin Howcroft
Journal:  Cancer Res       Date:  2016-07-18       Impact factor: 12.701

5.  URI1 amplification in uterine carcinosarcoma associates with chemo-resistance and poor prognosis.

Authors:  Yu Wang; Michael J Garabedian; Susan K Logan
Journal:  Am J Cancer Res       Date:  2015-06-15       Impact factor: 6.166

6.  An intersection network based on combining SNP coassociation and RNA coexpression networks for feed utilization traits in Japanese Black cattle.

Authors:  Daigo Okada; Satoko Endo; Hirokazu Matsuda; Shinichiro Ogawa; Yukio Taniguchi; Tomohiro Katsuta; Toshio Watanabe; Hiroaki Iwaisaki
Journal:  J Anim Sci       Date:  2018-06-29       Impact factor: 3.159

7.  The human RVB complex is required for efficient transcription of type I interferon-stimulated genes.

Authors:  Leonid Gnatovskiy; Paolo Mita; David E Levy
Journal:  Mol Cell Biol       Date:  2013-07-22       Impact factor: 4.272

8.  Upregulation of URI/RMP gene expression in cervical cancer by high-throughput tissue microarray analysis.

Authors:  Junxia Gu; Xiaoyun Li; Yuting Liang; Longwei Qiao; Deyuan Ran; Yaojuan Lu; Xingang Li; Wenxiang Wei; Qiping Zheng
Journal:  Int J Clin Exp Pathol       Date:  2013-03-15

9.  Expression analysis of URI/RMP gene in endometrioid adenocarcinoma by tissue microarray immunohistochemistry.

Authors:  Junxia Gu; Yuting Liang; Longwei Qiao; Xiaoyun Li; Xingang Li; Yaojuan Lu; Qiping Zheng
Journal:  Int J Clin Exp Pathol       Date:  2013-10-15

10.  Analysis of URI nuclear interaction with RPB5 and components of the R2TP/prefoldin-like complex.

Authors:  Paolo Mita; Jeffrey N Savas; Susan Ha; Nabil Djouder; John R Yates; Susan K Logan
Journal:  PLoS One       Date:  2013-05-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.